News Biohaven Shares Jump 70% After Agreeing to Be Bought by Pfizer in a $11.8B Deal Shares of migraine drug maker Biohaven soared nearly 70% after agreeing to be acquired by Pfizer for almost $11.6 billion in cash as ... By fxcoach10th May 20220